Nexgel, Inc.
NXGLNasdaqCIK 1468929HealthcareFiscal year ends Dec 31
Reports and events: 146 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0720:39 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-046154 |
| 2026-09-2420:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044149 |
| 2026-09-2321:20 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-043955 |
| 2026-08-2421:14 ET | DEF 14A | Proxy statementPeriod 2026-08-24 | 0001493152-26-039890 |
| 2026-08-2120:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-039708 |
| 2026-08-2016:39 ET | S-1 | Registration statement | 0001493152-26-039421 |
| 2026-08-1712:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038637 |
| 2026-08-1723:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038555 |
| 2026-08-0521:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036206 |
| 2026-07-2921:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-035258 |
| 2026-07-0920:15 ET | 8-K | 8.01 Other events | 0001493152-26-032687 |
| 2026-07-0221:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-031962 |
| 2026-06-1720:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029100 |
| 2026-06-0921:00 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001493152-26-027965 |
| 2026-05-1520:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-023851 |
| 2026-05-1421:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023207 |
| 2026-05-1220:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022503 |
| 2026-04-3020:54 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-020692 |
| 2026-04-3020:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020657 |
| 2026-04-2421:15 ET | 8-K | 3.01 Delisting notice | 0001493152-26-018962 |
| 2026-04-2120:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018302 |
| 2026-03-3121:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014377 |
| 2026-03-1013:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009474 |
| 2026-02-1113:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006124 |
| 2026-01-3022:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004535 |
| 2026-01-0721:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-000813 |
| 2025-12-1121:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-027245 |
| 2025-11-2421:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024829 |
| 2025-11-1213:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021742 |
| 2025-11-1213:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021738 |
| 2025-10-3020:15 ET | DEF 14A | Proxy statementPeriod 2025-10-30 | 0001493152-25-020224 |
| 2025-08-1221:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023236 |
| 2025-08-1220:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023188 |
| 2025-08-0520:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-022240 |
| 2025-08-0120:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021893 |
| 2025-07-3120:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-021743 |
| 2025-07-1420:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019508 |
| 2025-06-2020:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015860 |
| 2025-06-0420:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013634 |
| 2025-05-1321:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009988 |
| 2025-05-1320:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009954 |
| 2025-04-3021:01 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001641172-25-007863 |
| 2025-03-2720:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000937 |
| 2025-03-2513:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000533 |
| 2025-03-2420:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000311 |
| 2025-01-2214:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-003153 |
| 2025-01-0621:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-001000 |
| 2024-11-1400:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045238 |
| 2024-11-1322:29 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045213 |
| 2024-11-1214:04 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044582 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.